Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter
1Centre for Immunology and Infectious Disease, Blizard Institute of Cell and Molecular Science, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. d.w.wareham@qmul.ac.uk
Journal of Clinical Pathology
|December 7, 2010
Abstract:
Performance of CHROMagar Acinetobacter was assessed for the selective isolation and identification of Acinetobacter baumannii. The medium was effective in suppressing the growth of other Gram-positive and Gram-negative species while the addition of KPC supplement ensured growth of only carbapenem resistant A baumannii.
Related Concept Videos
00:57Antibiotic Selection
Overview
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...